At Cardiovascular Institute, we believe that our participation in clinical research gives us access to new data and information that continually improves the quality of care we provide to all of our patients. We’re proud to bring this level of commitment to treating cardiovascular disease to our community.
Patients who are considered a good candidate for a certain study by their provider are under no obligation to enroll. Your cardiologist and our research coordinators will provide you with comprehensive information to make an informed decision on your study participation and treatment options. While participation is voluntary, patients are asked to please consider their long term commitment to attend all follow-up appointments as part of their participation.
If you have any questions regarding your eligibility for studies that Cardiovascular Institute is currently participating in you may contact our research coordinators:
Shelley Sherk | Tia Radway at (850)769-0329
Links to trials actively enrolling at Cardiovascular Institute of Northwest Florida
Help take control of your heart and vascular health!
Participate in cholesterol medication research and learn more about managing your cholesterol and heart health.
What is being studied?
VictORION-INTERVENTION (or V-INTERVENTION, for short) is studying inclisiran, an injectable medicine that can help manage “bad” cholesterol with only two doses per year. Inclisiran is approved by the U.S. Food and Drug Administration (FDA) as a way to help lower cholesterol, along with a statin.
V-INTERVENTION seeks to understand how inclisiran works to prevent major cardiovascular or limb events, such as repeat revascularization, myocardial infarction, or stroke, in patients who have received or will receive a coronary or lower limb revascularization procedure.
Am I a good fit for this study?
You may be a good fit for V-INTERVENTION if you are an adult who is undergoing, or within 14 days of undergoing, an arterial revascularization procedure, such as angioplasty, endarterectomy, or bypass surgery.
Participating in V-INTERVENTION can help you learn more about how to help control your cholesterol. You may also want to take part to help doctors understand how to treat other people with high cholesterol.
To learn more information please go to ClinicalTrials.gov or reach out to one of our research coordinators.
ELEVATE-HFpEF
A clinical trial to evaluate how a personalized cardiac pacing rate will impact patients diagnosed with Heart Failure with preserved Ejection fraction (HFpEF).
What is this study?
In patients with HFpEF, the study will evaluate if pacing therapy influences patient outcomes, such as improved quality of life and fewer visits to the doctor and hospital. Once you have your pacemaker implanted, you will be randomly assigned to a trial group. You will not know which group you are in during the trial.
Pacemaker implant
This is a small medical device that is implanted under your skin. It continuously monitors your heart through wires that carry electrical signals to and from your heart. For patients whose heart beats too slowly, pacemakers can send signals to the heart to speed up the heart rate.
Who is eligible?
You may be eligible if you fit all of the following:
- Have a diagnosis of heart failure
- Have had a recent hospitalization or emergency room visit for worsening heart failure symptoms
- Do not currently have a pacemaker or similar device
To learn more information, please go to ClinicalTrials.gov or reach out to one of our research coordinators.
MEDTRONIC PRODUCT SURVEILLANCE REGISTRY
What is this study?
The main purpose of the Product Surveillance Registry is to evaluate long-term performance of Medtronic market-released cardiac rhythm products.
All Medtronic market-released leads and all market-released IPG, ICD and CRT devices are eligible to be included in this study.
Patients who receive a Medtronic device may qualify for this registry.
To learn more information, please reach out to one of our research coordinators.